A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D
Clinical trial NCT03546621 · COMPLETED
Trial details
- NCT number
- NCT03546621
- Sponsor
- Hepatera Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-16
- Primary completion
- 2018-01-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.